Bergenbio ASA Shares Owned By Institutions vs. Revenue

BGBIO Stock  NOK 9.22  0.17  1.88%   
Based on the key profitability measurements obtained from Bergenbio ASA's financial statements, Bergenbio ASA may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Bergenbio ASA's ability to earn profits and add value for shareholders.
For Bergenbio ASA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bergenbio ASA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bergenbio ASA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bergenbio ASA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bergenbio ASA over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Bergenbio ASA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bergenbio ASA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bergenbio ASA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bergenbio ASA Revenue vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bergenbio ASA's current stock value. Our valuation model uses many indicators to compare Bergenbio ASA value to that of its competitors to determine the firm's financial worth.
Bergenbio ASA is number one stock in shares owned by institutions category among its peers. It also is the top company in revenue category among its peers totaling about  40,376  of Revenue per Shares Owned By Institutions. Comparative valuation analysis is a catch-all model that can be used if you cannot value Bergenbio ASA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bergenbio ASA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Bergenbio Revenue vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Bergenbio ASA

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
19.17 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Bergenbio ASA

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
774 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Bergenbio Revenue vs Competition

Bergenbio ASA is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 10.38 Billion. Bergenbio ASA adds roughly 774,000 in revenue claiming only tiny portion of equities under Health Care industry.

Bergenbio ASA Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bergenbio ASA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bergenbio ASA will eventually generate negative long term returns. The profitability progress is the general direction of Bergenbio ASA's change in net profit over the period of time. It can combine multiple indicators of Bergenbio ASA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BerGenBio ASA, a clinical-stage biopharmaceutical company, develops medicines to treat immune evasive, drug resistant, and metastatic cancers. The company was founded in 2007 and is headquartered in Bergen, Norway. BerGenBio ASA is traded on Oslo Stock Exchange in Norway.

Bergenbio Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bergenbio ASA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bergenbio ASA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bergenbio ASA's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Bergenbio ASA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Economic Indicators Now

   

Economic Indicators

Top statistical indicators that provide insights into how an economy is performing
All  Next Launch Module

Use Investing Themes to Complement your Bergenbio ASA position

In addition to having Bergenbio ASA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Compulsion Thematic Idea Now

Compulsion
Compulsion Theme
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Bergenbio Stock

To fully project Bergenbio ASA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bergenbio ASA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bergenbio ASA's income statement, its balance sheet, and the statement of cash flows.
Potential Bergenbio ASA investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bergenbio ASA investors may work on each financial statement separately, they are all related. The changes in Bergenbio ASA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bergenbio ASA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.